Skip to main content

Table 4 Similar presentations of papillary thyroid carcinoma reported in the literature review

From: Plasma exchange as a rescue therapy for treatment-resistant thyroid storm with concurrent heart failure: a literature review based on a case report

Author, YOP

Age & Gender

CC, HX, PH/E, Lab, Imaging

DX, TX, Prog

Kwon S.H. et al., 2023 [39]

67/F

CC: Drowsiness, fever. HX: Type 2 DM, HTN, total thyroidectomy 4 years prior. PH/E: Fever, tachycardia. Lab: Severe thyrotoxicosis (TSH < 0.008, T4 > 12.0 ng/dL). Imaging: PET/CT with pelvic bone metastasis.

DX: Thyroid storm due to metastatic PTC. TX: Antithyroid regimen, beta-blockers, corticosteroids. Prog: Died on day 6 after hospitalization.

Arosemena et al., 2022 [56]

32/M

CC: Weight loss (20 lbs). HX: No known past medical history, hyperthyroidism with elevated T4 and T3. PH/E: Non-enlarged thyroid, no orbitopathy. Lab: TSH < 0.01, TSI 8, Tg 53 ng/mL. Imaging: Hypervascular nodule, thyroid uptake scan 70.2%.

DX: Graves' disease and PTC. TX: Thyroidectomy, RAI therapy, BRAF V600E positive. Prog: Stable, awaiting 6-month follow-up.

Hu et al., 2020 [57]

Case 1: 55/F

Case 2: 43/F

Case 1: CC: Cervical mass, tremors, hyperactive mood. HX: GD, right AFTN. PH/E: Palpable nodule. Lab: TSH < 0.004, T4 227.6, TRAb 14.42. Imaging: 4 cm adenoma with PTC.

Case 2: CC: Cervical mass. HX: HD. PH/E: Right lobe nodule. Lab: TSH < 0.01, T4 250.7. Imaging: Right hyperfunctioning nodule (0.4 cm).

Case 1: DX: Marine-Lenhart syndrome with bilateral PTC. TX: Total thyroidectomy. Prog: Stable.

Case 2: DX: Toxic nodular goiter with PTC. TX: Right hemithyroidectomy. Prog: Stable.

Krishnaja et al., 2019[58]

63/F

CC: Headache, soft-tissue swelling on scalp, palpitations, anxiety, weight loss. HX: Post-thyroidectomy for PTC, defaulted treatment. PH/E: High pulse (112 bpm), tremors, staring look. Lab: Tg > 481 ng/mL, TSH 0.03 mIU/L. Imaging: I-131 scan showing lung, skeletal, and lymph node metastasis.

DX: Metastatic PTC with thyrotoxicosis. TX: HDRAI, thyroxine suppression therapy. Prog: Improvement of thyrotoxicosis but persistent metastases.

Pinto et al., 2019 [59]

71/F

CC: Back pain, leg weakness. HX: HTN, A-Fib, CHF, CKD. PH/E: Sacral mass on MRI. Lab: TSH <0.01, T4 > 8.0 ng/dL, TG 79,090 ng/mL. Imaging: 12.4 cm sacral mass with metastasis to S1-S5.

DX: Thyroid storm with coma due to metastatic PTC and GD. TX: Antithyroid drugs, steroids, therapeutic plasma exchange, thyroidectomy. Prog: Died despite resolution of thyroid storm.

Sacks et al., 2013 [32]

37/M

CC: Painless lump in neck. HX: Multifocal, bilateral PTC with lymphovascular invasion and extra nodal extension. PH/E: Palpable lymphadenopathy. Lab: Tg > 3000 ng/mL. Imaging: Neck and chest CT, ultrasound showing diffuse malignant lymphadenopathy.

DX: Aggressive metastatic PTC. TX: Thyroidectomy, lymph node dissection, RAI therapy, EBRT. Prog: Stable disease with decreased lung nodules, but persistent metastases.

  1. Abbreviations: A-Fib Atrial Fibrillation, CC Chief Complaint, CHF Congestive Heart Failure, CKD Chronic Kidney Disease, DM Diabetes Mellitus, DX Diagnosis, EBRT External Beam Radiation Therapy, GD Graves' Disease, HD Hashimoto's Disease, HDRAI High-Dose Radioactive Iodine, HTN Hypertension, HX History, PET/CT Positron Emission Tomography/Computed Tomography, PH/E Physical Examination, PTC Papillary Thyroid Carcinoma, RAI Radioactive Iodine, T4 Thyroxine, Tg Thyroglobulin, TRAb Thyroid Stimulating Hormone Receptor Antibodies, TSH Thyroid Stimulating Hormone, TX Treatment, TSI Thyroid Stimulating Immunoglobulin, YOP Year of Publication